Personalis Free Cash Flow 2018-2024 | PSNL
Personalis free cash flow from 2018 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Personalis Annual Free Cash Flow |
| 2023 |
-67.17 |
| 2022 |
-120.13 |
| 2021 |
-81.91 |
| 2020 |
-45.90 |
| 2019 |
-26.45 |
| 2018 |
-2.28 |
| 2017 |
-4.87 |
| Personalis Quarterly Free Cash Flow |
| 2024-09-30 |
-37.47 |
| 2024-06-30 |
-31.03 |
| 2024-03-31 |
-20.52 |
| 2023-12-31 |
-67.17 |
| 2023-09-30 |
-50.23 |
| 2023-06-30 |
-32.68 |
| 2023-03-31 |
-19.52 |
| 2022-12-31 |
-120.13 |
| 2022-09-30 |
-93.83 |
| 2022-06-30 |
-57.65 |
| 2022-03-31 |
-19.99 |
| 2021-12-31 |
-81.91 |
| 2021-09-30 |
-63.06 |
| 2021-06-30 |
-42.22 |
| 2021-03-31 |
-12.18 |
| 2020-12-31 |
-45.90 |
| 2020-09-30 |
-42.53 |
| 2020-06-30 |
-24.85 |
| 2020-03-31 |
-8.72 |
| 2019-12-31 |
-26.45 |
| 2019-09-30 |
-26.94 |
| 2019-06-30 |
-13.64 |
| 2019-03-31 |
-0.89 |
| 2018-12-31 |
|
| 2018-09-30 |
-4.81 |
| 2018-06-30 |
-2.44 |
| 2017-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.354B |
$0.073B |
|
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
|
